醫(yī)學(xué)全在線
醫(yī)學(xué)全在線首頁-醫(yī)師-藥師-護(hù)士-衛(wèi)生資格-高級職稱-考試題庫-網(wǎng)校-考研-圖譜-下載-招聘  
分類
國家級省級浙江省各省雜志
科技核心北大核心CSCDCSCD擴(kuò)展
工具
期刊知識寫作指導(dǎo) 論文投稿推薦期刊
期刊驗(yàn)證論文檢測 錄用通知往期目錄
SCI
SCI指導(dǎo)影響因子
期刊點(diǎn)評基金動態(tài)
其它
經(jīng)濟(jì)教育計(jì)算機(jī)
建筑體育農(nóng)業(yè)
北京|天津|河北|山西|湖北|江蘇|安徽|山東|上海|浙江|江西|福建|湖南|寧夏|內(nèi)蒙古|河南
四川|重慶|貴州|云南|遼寧|吉林|廣東|廣西|海南|陜西|甘肅|新疆|青海|衛(wèi)生部直屬|黑龍江|兵團(tuán)
您現(xiàn)在的位置: 醫(yī)學(xué)全在線 > 醫(yī)學(xué)論文 > 論文投稿 > 正文:環(huán)磷腺苷葡胺聯(lián)合參麥治療支氣管哮喘療效觀察
    

醫(yī)學(xué)論文范文:環(huán)磷腺苷葡胺聯(lián)合參麥治療支氣管哮喘療效觀察

來源:本站原創(chuàng) 更新:2013-9-5 論文投稿平臺

醫(yī)學(xué)論文范文:環(huán)磷腺苷葡胺聯(lián)合參麥治療支氣管哮喘療效觀察

【摘要】 目的 探討環(huán)磷腺苷葡胺聯(lián)合參麥治療支氣管哮喘的臨床療效。方法 100例支氣管哮喘患者隨機(jī)分為研究組和對照組,每組50例,研究組在常規(guī)治療基礎(chǔ)上加用環(huán)磷腺苷葡胺150 mg和參麥注射液40 ml,1次/d,連用14 d,監(jiān)測2組的癥狀控制時間、肺通氣功能和血?dú)夥治觥A魇郊?xì)胞儀檢測外周血中T細(xì)胞亞群CD4、CD8、CD4/CD8、CD69、CD+3T淋巴細(xì)胞、CD+69CD+4T淋巴細(xì)胞水平。結(jié)果 研究組治療后VC、FEV1、PEF高于對照組(P<0.05),研究組PaO2增加值和PaCO2下降值高于對照組(P<0.05);研究組患者治療后CD4、CD4/CD8、CD69CD+3T淋巴細(xì)胞和CD69CD+4T淋巴細(xì)胞低于對照組(P<0.05),CD8高于對照組(P<0.05)。 結(jié)論 環(huán)磷腺苷葡胺聯(lián)合參麥治療支氣管哮喘有顯著療效,且能增加支氣管哮喘患者的免疫功能。

【關(guān)鍵詞】 環(huán)磷腺苷葡胺;參麥注射液;哮喘;治療效果

Therapeutic effects of MCAMP combined with shenmai injection on bronchial asthma YANG Wei, TANG Jihong, WANG Xiongbiao. Department of Respiratory,Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China

【Abstract】 Objective To investigate the therapeutic effect of MCAMP combined with shenmai injection on asthma.Methods 100 patients with asthma were randomly divided into the research group and the control group, each group had 50 cases. The patients in control group were treated with routine western medicine, while the patients in research group,based on the same therapy as control group,were treated with MCAMP 150mg a day and Shenmai injection 40ml a day infused intravenously for 14 days. The lung function, blood gas and T cell levels (CD4,CD8,CD4/CD8, CD69CD+3 and CD69CD+4) were measured for both groups.Results In research group after treatment the VC increased to (426±123)ml,the FEVl increased to (264±55)ml,the PEF increased to (0.8±0.3)L/s, the PaO2 increased to (+3.8±1.5)kPa, the PaCO2 increased to (-3.10±1.21)kPa and CD8 increased to (29.41±7.32)%.All of the seven parameters were significantly higher than those in control group[ (311±146)ml, (195±52)ml,(0.5±0.3)L/s,(+2.23±1.26)kPa,(-2.0±1.0)kPa,(26±7)respectively](P<0.05).The levels of CD4,CD4/CD8,CD69CD+3 and CD69CD+4 in research group [(44±5)%,(1.41±0.09),(8.2±2.4)%,(3.5+1.9)% respectively] were significantly reduced, as compared with those in control group [(49±6)%,(1.91±0.29)%,(9.9±2.5)%,(6.5±2.2)%](P<0.05). Conclusion MCAMP combined with Shenmai injection is effective in treating bronchial asthma,which can improve the immunity function of patients醫(yī).學(xué)全.在.線網(wǎng)站m.f1411.cn.

【Key words】 MCAMP; shenmai; asthma; effect


[1] [2] [3] [4] [5] 下一頁

...
關(guān)于我們 - 聯(lián)系我們 -版權(quán)申明 -誠聘英才 - 網(wǎng)站地圖 - 網(wǎng)絡(luò)課程 - 幫助
醫(yī)學(xué)全在線 版權(quán)所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP備12017320號
百度大聯(lián)盟認(rèn)證綠色會員實(shí)名網(wǎng)站 360認(rèn)證可信網(wǎng)站 中網(wǎng)驗(yàn)證